{"transactions":[{"id":683816,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22339,"kind":"person","name":"Hallett David","position":1,"cik":"0002006495","reported_name":"Hallett David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Class A Common Stock","published_at":"2026-08-18T21:44:29.000Z","date":"2026-08-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":26657,"price":3.16,"value":84236.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":1043837,"source":{"system":"sec-edgar","filing":"0002006495-26-000012","document":"wk-form4_1787089466.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2006495/000200649526000012/wk-form4_1787089466.xml","form_type":"4"}},{"id":772504,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22339,"kind":"person","name":"Hallett David","position":1,"cik":"0002006495","reported_name":"Hallett David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Class A Common Stock","published_at":"2026-05-19T21:54:56.000Z","date":"2026-05-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":26657,"price":3.04,"value":81037.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":1070494,"source":{"system":"sec-edgar","filing":"0002006495-26-000010","document":"wk-form4_1779227693.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2006495/000200649526000010/wk-form4_1779227693.xml","form_type":"4"}},{"id":893690,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22339,"kind":"person","name":"Hallett David","position":1,"cik":"0002006495","reported_name":"Hallett David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-20T00:30:57.000Z","date":"2026-02-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":11908,"price":3.49,"value":41558.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":1097151,"source":{"system":"sec-edgar","filing":"0001601830-26-000022","document":"wk-form4_1771547454.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2006495/000160183026000022/wk-form4_1771547454.xml","form_type":"4"}},{"id":912335,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22339,"kind":"person","name":"Hallett David","position":1,"cik":"0002006495","reported_name":"Hallett David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-10T23:18:12.000Z","date":"2026-02-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":11400,"price":3.98,"value":45372.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units."}],"balance_after":1109059,"source":{"system":"sec-edgar","filing":"0001601830-26-000012","document":"wk-form4_1770765490.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2006495/000160183026000012/wk-form4_1770765490.xml","form_type":"4"}},{"id":912334,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22339,"kind":"person","name":"Hallett David","position":1,"cik":"0002006495","reported_name":"Hallett David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-10T23:18:12.000Z","date":"2026-02-06","kind":"grant","planned":false,"acquired":true,"shares":24254,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This RSU vested immediately upon the grant date."}],"balance_after":1120459,"source":{"system":"sec-edgar","filing":"0001601830-26-000012","document":"wk-form4_1770765490.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2006495/000160183026000012/wk-form4_1770765490.xml","form_type":"4"}},{"id":912333,"issuer":{"id":1008,"kind":"organization","name":"RECURSION PHARMACEUTICALS, INC.","symbol":"RXRX"},"owners":[{"id":22339,"kind":"person","name":"Hallett David","position":1,"cik":"0002006495","reported_name":"Hallett David","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Class A Common Stock","published_at":"2026-02-10T23:18:12.000Z","date":"2026-02-06","kind":"grant","planned":false,"acquired":true,"shares":502064,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This RSU vests as to one one-sixteenth (1/16th) of the units subject the RSU on May 15, 2026 and every three months thereafter."}],"balance_after":1096205,"source":{"system":"sec-edgar","filing":"0001601830-26-000012","document":"wk-form4_1770765490.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2006495/000160183026000012/wk-form4_1770765490.xml","form_type":"4"}}]}